The largest database of trusted experimental protocols

Ppic9 vector

Manufactured by Thermo Fisher Scientific
Sourced in United States

The PPIC9 vector is a plasmid DNA vector designed for cloning and expressing recombinant proteins in various cell lines. The vector contains the necessary genetic elements, such as a promoter, multiple cloning sites, and selection markers, to facilitate the insertion and expression of target genes. The core function of the PPIC9 vector is to provide a standardized platform for the production of recombinant proteins in a laboratory setting, without making any claims about its intended use or applications.

Automatically generated - may contain errors

8 protocols using ppic9 vector

1

Lignocellulose Degradation by Talaromyces

Check if the same lab product or an alternative is used in the 5 most similar protocols
Talaromyces leycettanus JCM12802 (Japan Collection of Microorganisms RIKEN BioResource Center, Tsukuba, Japan) was cultured in medium containing lignocellulose as the sole carbon source at 45 °C for 3 days [32 (link)]. Escherichia coli strain Trans I-T1 and the pEASY-T3 vector (TransGen, Beijing, China) were employed for DNA manipulation. P. pastoris GS115 and the pPIC9 vector (Invitrogen, Carlsbad, CA, USA) were used for heterologous gene expression.
+ Open protocol
+ Expand
2

Recombinant Production of ChtI Enzyme Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The gene fragment encoding OfChtI-CAD (residues 19–407) was amplified from the full-length cDNA of OfChtI (GenBank ID DQ294305) with the primers 5′-TGAAGC­TTACGTAGAATTCGCGGAGTCGGACAGCAGAGCG-3′ (forward) and 5′-CCGCCCTAGGGAATTCTTAATGATGATGATGATGATGAGAACGCGGTGGTGGAACAG-3′ (reverse). EcoRI restriction sites (bold) and a C-terminal 6×His affinity tag were introduced. The resulting PCR fragment was ligated into the pPIC9 vector (Invitrogen, Carlsbad, Califonia, USA) with an in-fusion HD cloning kit (Clontech, Palo Alto, California, USA).
The OfChtI-CAD E148Q, E148A, F159A, F194A, W241A, Y290A, F194A/W241A, F159A/Y290A and F159A/F194A/W241A/Y290A mutants were produced using the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, California, USA), according to the manufacturer’s instructions. The mutated genes were sequenced to confirm that the desired mutations had been inserted.
+ Open protocol
+ Expand
3

Constructing pPic9abaecin Plasmid

Check if the same lab product or an alternative is used in the 5 most similar protocols
The insert was removed from vector pUC57 using the NotI and EcoRI enzymes. The vector pPic9 was also digested with the same enzymes, quantified and dephosphorylated with SAP enzyme. It was used 16.7 ng of the insert in the ligation reaction with 50 ng of pPIC9 vector and 1U of the DNA ligase I (Invitrogen) at 14 °C overnight. The product of this reaction was named pPic9abacin, confirmed by electrophorese at 0.8% of agarose. The Escherichia coli Top10 bacteria were transformed with the pPic9abaecin by electroporation in 0.2 cm cuvette with lysogeny broth (LB), following the parameters: 2.5 kV, 200 Ω and 25 µF, electroporated in Bio-Rad Gene Pulser (Bio-Rad). These clones were cultivated in LB medium containing 50 µg/mL of Ampicillin. The plasmid extraction was performed using QIAprep® (Qiagen®), following the kit protocol.
+ Open protocol
+ Expand
4

Influenza Virus Propagation and Inactivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Influenza A viruses, A/Philippines/2/1982 (A/Phil, H3N2) and A/PR/8/1934 (A/PR8, H1N1) kindly provided by Dr. Huan Nguyen, A/California/04/2009 (A/CA04, H1N1) generously provided by Dr. Richard Webby and reassortant A/Vietnam/1203/2004 (A/VN1203, rgH5N1 containing HA with polybasic residues removed and NA from A/VN1203 and 6 internal genes from A/PR/8/1934) (Song et al., 2010 (link)), were propagated in 10-day-old embryonated eggs as previously described (Song et al., 2010 (link)). The influenza virus was inactivated by mixing the virus with formalin at a final concentration of 1:4,000 (v/v) as described previously (Lee et al., 2014b (link)). Monovalent seasonal influenza split vaccine (Green Cross, South Korea) used in this study was derived from NYMC X-187 (X-187, HA and NA were derived from A/Victoria/210/2009 (H3N2) and the backbone genes from A/PR8 virus). P. pastoris strain GS115 and the pPIC9 vector were purchased from Life Technologies (Grand Island, NY). Adjuvant System 04 (AS04) is consisted of MPL (3-O-desacyl-4’-monophosphoryl lipid A, Sigma-Aldrich, St Louis, MO) and aluminum hydroxide (Alum, Sigma–Aldrich).
+ Open protocol
+ Expand
5

Expression and Purification of M2e5x Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
M2e5x protein was expressed from yeast. In brief, DNA fragment of M2e5x construct was cloned into the pPIC9 vector (Life technology, NY, USA) for secretory expression in the yeast. The recombinant plasmid was transformed into P. pastoris strain GS115, phenotype Mut+ (methanol utilization plus) by electroporation (Life Technologies). P. pastoris transformants were inoculated into BMGY medium (1% yeast extract, 2% peptone, 1.34% YNB, 1%glycerol, 100 mM potassium phosphate, pH 6.0) and incubated at 30°C for 48 h under vigorous agitation (240 rpm). For the induction of the M2e5x protein, the yeast transformants were transferred to BMMY medium (the same components as those of BMGY with glycerol replaced by 0.5% methanol). Methanol was added to a final concentration of 1% (v/v) on the second day and increased to 1.5% (v/v) on the third and fourth days. The culture was kept at 30°C with agitation for 72 h. Then the supernatants were recovered. M2e5x proteins were purified by ion exchange chromatography on Q-Sepharose (GE Healthcare, PA) followed by hydrophobic interaction chromatography on phenyl-Sepharose 6FF column (GE Healthcare, PA).
+ Open protocol
+ Expand
6

Recombinant X24 Protein Expression in Pichia

Check if the same lab product or an alternative is used in the 5 most similar protocols
The X24 gene from P. cryptogea with α-secretion factor (Saccharomyces cerevisiae) was inserted into a pPIC9 vector (Life Technologies, USA). In addition, a glycine residue was added on the N-terminus of the recombinant protein in order to improve the processing ability of the KEX2 protease (α-secretion factor cleavage). A QuikChange kit (Stratagene, France) for direct mutagenesis was then used to construct the desired expression vectors by using oligonucleotides listed in Supplementary Table S1. All vectors were validated by DNA sequencing. The constructed vectors were transformed into Pichia pastoris strain GS115. Screening for optimal protein production was performed and the most suitable strain was cultivated in a Biostat B-DCU bioreactor (Sartorius, Germany) using a previously described protocol (Wood and Komives, 1999 (link)). The expressed proteins were purified by ultrafiltration and Fast Protein Liquid Chromatography using a Source S15 column as described before (Pleskova et al., 2011 (link)). The molecular weights (MW) of the purified proteins were determined by MALDI-TOF spectroscopy.
+ Open protocol
+ Expand
7

Protein Expression in E. coli and P. pastoris

Check if the same lab product or an alternative is used in the 5 most similar protocols
Escherichia coli BL21 (DE3) (Transgen, China) was used as the host for prokaryotic protein expression. It was grown aerobically in Luria–Bertani broth with 100 µg of ampicillin/mL. The vector pET-22b(+) and shuttle vector pPIC9 (Invitrogen, China) were used for secretion of target proteins. All enzymes were purchased from Takara (Japan). Primers and genes were synthesised by Tsingke Biotech (China). P. pastoris GS115 (Invitrogen, Beijing, China) was used as the host for eukaryotic protein expression. The culture media were: minimal dextrose (MD), yeast extract peptone dextrose (YPD), buffered glycerol-complex (BMGY) and buffered methanol-complex (BMMY). All chemical reagents were of analytical pure grade.
+ Open protocol
+ Expand
8

Cloning and Expression of Xylanase in Pichia pastoris

Check if the same lab product or an alternative is used in the 5 most similar protocols

T. leycettanus JCM12802 was grown in potato dextrose Broth (PDB). Escherichia coli Trans1-T1 was used for gene cloning. Vector pPIC9 (Invitrogen, Carlsbad, CA) was used for gene expression by being transformed into Pichia pastoris GS115. Beechwood xylan was purchased from Sigma-Aldrich (St. Louis, MO). The DNA purification kit, LA Taq DNA polymerase and restriction endonucleases were purchased from TaKaRa (Otsu, Japan). The total RNA isolation system kit and T4 DNA ligase were purchased from Promega (Madison, WI). All chemicals were of analytical grade and commercially available.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!